http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-073677-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b86ef86a8b00f49ca5a1c9a3bd58f41d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
filingDate 2009-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-073677-A1
titleOfInvention CYCLE DERIVATIVES OF BENZIMIDAZOL PROTEINQUINASA ACTIVATORS OF AMP, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME IN THE TREATMENT OF TYPE II, OBESITY AND OTHER DISEASES.
abstract Claim 1: A compound of structural formula 1: or a pharmaceutically acceptable salt thereof, wherein: X is absent or selected from; (24) -CH2-, (25) -CHF-, (26) -CF2-, (27) -S-, (28) -O-, (29) -O-CH2-, (30) -NH- , (31) -C (O) -, (32) -NHC (O) -, (33) -C (O) NH-, (34) -NHSO2-, (35) -SO2NH-, and (36) -CO2-, where each CH2 is unsubstituted or substituted by 1 or 2 substituents selected from: hydroxy, halogen, NH2, C1-6 alkyl, CO2H, CO2 C1-6 alkyl, CO C1-6 alkyl, phenyl and -CH2phenyl, and where each NH is unsubstituted or substituted by 1 substituent selected from: C1-6 alkyl, CO2H, CO2 C1-6 alkyl, CO C1-6 alkyl, phenyl and -CH2phenyl; And is selected from: (6) C3-10 cycloalkyl, (7) C3-10 cycloalkenyl, (8) C2-10 cycloheteroalkyl, (9) C2-10 cycloheteroalkenyl, (10) aryl, and (11) heteroaryl, where the cycloalkyl , cycloalkenyl, cycloheteroalkyl, cycloheteroalkenyl, aryl and heteroaryl are unsubstituted or substituted by 1, 2, 3 or 4 substituents selected from Rb is selected from: (35) oxo, (36) -CN, (37) - (CH2) nCO2H , (38) - (CH2) nCO2Ri, (39) - (CH2) nOH, (40) - (CH2) nC (O) NHRg, (41) - (CH2) nNHC (O) C1-6 alkyl, (42 ) - (CH2) nNHSO2Ri, (43) - (CH2) nSO2NHRg, (44) (CH2) nSO2NHC (O) Ri, (45) - (CH2) nSO2NHCO2Ri, (46) - (CH2) nSO2NHCON (Rg) 2, (47) - (CH2) nC (O) NHSO2Ri, (48) - (CH2) nNHC (O) N (Rg) 2, (49) - (CH2) C3-10-CO2Recycloalkyl alkyl, (50) heteroaryl, ( 51) -C2-10 cycloheteroalkenyl, and (52) -C2-10 cycloheteroalkyl, where each CH2 is unsubstituted or substituted by 1 or 2 substituents selected from C1-6 alkyl, -OH and -NH2, where each NH is unsubstituted or substituted by 1 substituent selected from Rc , and where each alkyl, cycloalkyl, cycloheteroalkyl, cycloheteroalkenyl, aryl and heteroaryl is unsubstituted or substituted by 1, 2, 3 or 4 substituents selected from Rc; each R1 and R2 is independently selected from: (1) hydrogen, (2) halogen, (3) -CH, (4) -CF3, (5) -C1-6 alkyl, (6) -C2-6 alkenyl, ( 7) C2-6 alkynyl, (8) - (CH2) C3-10 cycloalkyl, (9) (CH2) pcicIoaC3-7-aryl alkyl, (10) - (CH2) C3-7-cycloalkyl-heteroaryl, (11) - (CH2) C4-10 cycloalkenyl, (12) - (CH2) C4-7-aryl cycloalkenyl, (13) - (CH2) C4-7-heteroaryl cycloalkenyl, (14) - (CH2) C2-10 cycloheteroalkyl, (15 ) - (CH2) C2-10 pcicIoheteroaqueniIo, (16) - (CH2) paryl, (17) biphenyl, (18) - (CH2) pheteroaryl, (19) -C2-6 -alkenyl, (20) -C2 alkenyl -6-aryl, (21) -C2-6 alkenyl-heteroaryl, (22) -C2-6-alkenyl C3-7, (23) -C2-alkenyl 6 -6-C3-7 cycloalkenyl, (24) -C2-alkenyl C2-7 6-cycloheteroalkyl, (25) -C2-6 -alkenyl C2-7 cycloheteroalkenyl, (26) -C2-6 -alkynyl-(CH2) 1-3-O-aryl, (27) -C2-6 -alkyl alkyl, (28) -C2-6 -alkyl-aryl, (29) -C2-6 -alkyl-heteroaryl, (30) -C2-6 -alkyl-C3-7 -alkyl, (31) -C2-6 -alkyl-C3- cycloalkenyl 7, (32) -alquin C2-6 -C3-7cycloheteroalkyl, (33) -C2-6 -alkyl-C2-7 cycloheteroalkenyl, and (34) -C (O) NH- (CH2) 0-3phenyl, where each CH2 is unsubstituted or substituted by 1 or 2 substituents selected from: halogen, CF3, -OH, -NH2, -C 1-6 alkyl, -C 1-6 alkyl, -NC 1-6 alkyl and -N (C 1-6 alkyl) 2, where each alkyl , alkenyl and alkynyl is unsubstituted or substituted by 1, 2 or 3 substituents selected from: halogen, CF3, -OH, -NH2, -C1-6 alkyl, -C1-6 alkyl, -N C1-6 alkyl and -N ( alkyl and where each cycloalkyl, cycloalkenyl, cycloheteroalkyl, cycloheteroalkenyl, phenyl, aryl and heteroaryl is unsubstituted or substituted by 1, 2, 3 or 4 substituents independently selected from Ra, with the proviso that at least one of only one of R1 and R2 is selected from the group consisting of: hydrogen, halogen, -CN, -CF3, -C1-6 alkyl, -C2-6 alkenyl and -C2-6 alkynyl, and with the proviso that if R1 or R2 is hydrogen , then at least one of R3 and R4 don't be hydrogen; R3 and R4 are each independently selected from: (5) hydrogen, (6) halogen, (7) -C1-6 alkyl, (8) -C2-6 alkenyl, (9) -C2-6 alkynyl, (10 ) -C3-10 cycloalkyl, (11) -C3-10 cycloalkenyl, (12) aryl, (13) heteroaryl, (14) -CN, (15) -CF3, (16) -OH, (17) -C1 alkyl -6, (18) -NH2, (19) -NH1-6alkyl, (20) -N (C1-6alkyl) 2, (21) -C1-6alkyl, (22) -SO1-6alkyl, ( 23) -SO2 C1-6 alkyl, (24) -NHSO2 C1-6 alkyl, (25) -NHC (O) C1-6 alkyl, (26) -SO2N C1-6 alkyl, and (27) -C (O) NH C1 alkyl -6; R5 is selected from: (7) hydrogen, (8) -C1-6 alkyl, (9) -CH2CO2H, and (10) -CH2CO2C1-6 alkyl; each Ra is independently selected from the group consisting of: (1) halogen, (2) oxo, (3) - (CH2) mOH, (4) (CH2) mN (Rj) 2, (5) (CH2) mNO2 , (6) (CH2) mCN, (7) -C1-6 alkyl, (8) - (CH2) mCF3, (9) - (CH2) mOCF3, (10) -OCH2 or C1-6 alkyl, (11) -OCH2 -aryl, (12) - (CH2) mC (= N-OH) N (Rj) 2, (13) - (CH2) mC 1-6 alkyl, (14) - (CH2) mO-aryl, (15) - OCH2phenyl, (16) (CH2) m C1-6 alkyl, (17) (CH2) mS (O) C1-6 alkyl, (18) - (CH2) mS (O) 2 C1-6 alkyl, (19) - (CH2 ) mNHS (O) 2 C1-6 alkyl, (20) - (CH2) mC (O) Rf, (21) (CH2) mC (O) N (Rj) 2, (22) - (CH2) mN (Rj) C (O) Rf, (23) - (CH2) mN (Rj) C (O) N (Rj) 2, (24) - (CH2) mCO2H, (25) - (CH2) mOC (O) H, ( 26) (CH2) mCO2Rf, (27) - (CH2) mOC (O) Rf, (28) - (CH2) C3-7 cycloalkyl, (29) - (CH2) C3-7 cycloalkenyl, (30) - (CH2 ), C2-6 cycloheteroaIquIo, (31) - (CH2) C2-6 cycloheteroaIquenyl, (32) - (CH2) rnaryl, and (33) - (CH2) mheteroaryl, where each CH2 is unsubstituted or substituted by 1 or 2 substituents selected from: oxo, - (CH2) 0-3OH, -CN, -NH2, -NH (C1-6 alkyl), -N (C1-6 alkyl) 2, -C1 alkyl 6, -C1-6alkyl, halogen, -CH2F, -CHF2, -CF3, -CO2H, -CO2C1-6alkyl, -C3-7cycloalkyl, phenyl, CH2phenyl, heteroaryl and CH2heteroaryl, and where alkyl, cycloalkyl, cycloheteroalkyl , phenyl, aryl and heteroaryl are unsubstituted or substituted by 1, 2, 3 or 4 substituents selected from: oxo, - (CH2) 0-3OH, -CN, -NH2, -NH (C1-6 alkyl), -N (C1-6 alkyl) 2, -C1-6 alkyl, -C1-6 alkyl, halogen, -CH2F, -CHF2, -CF3, -CO2H, -CO2C1-6 alkyl, -C3-7 cycloalkyl, phenyl, CH2phenyl, heteroaryl and CH2heteroaryl; each Rb is independently selected from: (14) hydrogen, (15) -C1-6 alkyl, (16) -C3-6 cycloalkyl, (17) -C3-6 cycloalkenyl, (18) -C3-6 cycloheteroalkyl, (19 ) aryl, (20) heteroaryl, (21) halogen, (22) -OH, (23) -NO2, (24) -NH2, (25) -NH (C1-6 alkyl), (26) -N (alkyl C1-6) 2, (27) -C1-6 alkyl, (28) - (CH2) qCO2H, (29) - (CH2) qCO2C1-6 alkyl, (30) -CF3, (31) -CN (32) -SO2 C1-6alkyl, and (33) - (CH2) qCON (Re) 2, where each CH2 is unsubstituted or substituted by 1 or 2 halogens, and where each alkyl, cycloalkyl, cycloalkenyl, cycloheteroalkyl, aryl and heteroaryl are without substitute or replace with 1, 2 or 3 halogens; each Rc is independently selected from: (21) halogen, (22) oxo, (23) - (CH2) rOH, (24) - (CH2) rN (Re) 2, (25) - (CH2) rCN, (26 ) -C1-6 alkyl, (27) -CF3, (28) -C1-6 alkyl-OH, (29) -OCH2C1-6 alkyl, (30) - (CH2) C1-6 alkyl, (31) -OCH2aryl , (32) - (CH2) r C1-6 alkyl, (33) - (CH2) rC (O) Rf, (34) - (CH2) rC (O) N (Re) 2, (35) - (CH2) rCO2H, (36) - (CH2) rCO2Rf, (37) - (CH2) C3-7cycloalkyl, (38) - (CH2) C2-6cycloheteroalkyl, (39) - (CH2) raryl, and (40) - ( CH2) rheteroaryl, where each CH2 is unsubstituted or substituted by 1 or 2 substituents selected from: oxo, -OH, -CN, -N (Rh) 2, -C1-6 alkyl, -C1-6 alkyl, halogen, - CHF2, -CHF2, -CF3, -CO2H, -CO2C1-6 alkyl, -C3-7cycloalkyl and heteroaryl, and where the alkyl, cycloalkyl, cycloheteroalkyl, aryl and heteroaryl are unsubstituted or substituted by 1, 2, 3 or 4 substituents selected from: oxo, -OH, -CN, -N (Rh) 2, -C1-6 alkyl, -C1-6 alkyl, halogen, -CHF2, -CHF2, -CF3, -CO2H, -CO2C1-6 alkyl , C3-7 cycloalkyl and het eroaryl; each Re, Rg and Rh is independently selected from: (1) hydrogen, and (2) alkyl where the alkyl is unsubstituted or substituted by 1, 2, 3 or 4 substituents selected from: -OH, oxo, halogen, alkyl - C1-6alkyl, -NH2, -NH (C1-6 alkyl) and -N (C1-6 alkyl) 2; each Rj is independently selected from: (1) hydrogen, (2) C1-6 alkyl, (3) C3-6 cycloalkyl, (4) -C (O) Ri, and (5) -SO2Ri, where the alkyl and the Cycloalkyl are unsubstituted or substituted by 1, 2, 3 or 4 substituents selected from: -OH, oxo, halogen, C1-6 alkyl, -C1-6 alkyl, -NH2, -NH (C1-6 alkyl) and -N (C1-6 alkyl) 2; each Rf and Ri is independently selected from: (19) C1-6 alkyl, (20) C4-7 cycloalkyl, (21) C4-7 cycloalkenyl, (22) C3-7 cycloheteroalkyl, (23) C3-7 cycloheteroalkenyl, ( 24) aryl, and (25) heteroaryl, wherein alkyl, cycloalkyl, cycloalkenyl, cycloheteroalkyl, cycloheteroalkenyl, aryl and heteroaryl are unsubstituted or substituted by 1, 2, 3 or 4 substituents selected from: oxo, -OH, -CN, -NH2, -C1-6alkyl, -C1-6alkyl, halogen, -CH2F, -CHF2, -CF3, -CO2H, -CO2C1-6alkyl, -C3-7cycloalkyl and heteroaryl; n is 0, 1, 2, 3 or 4; m is 0, 1, 2, 3 or 4; p is 0, 1, 2 or 3; q is 0, 1, 2, 3 or 4; and r is 0, 1 or 2.
priorityDate 2008-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409283606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5798

Total number of triples: 31.